MedTrace Logo

Prognostic Significance of Lymph Node Yield and Lymph Node Ratio Prospective Observational Study

NCT03534778 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 350

Last updated 2019-04-19

No results posted yet for this study

Summary

It is still unclear if Lymph Node Yield (LNY) and Lymph Node Ratio (LNR) may have a prognostic role in patients affected by carcinoma of the oral cavity and the oropharynx. Only retrospective studies are available. For this reason, this prospective, multi center, observational study should provide indications in this regard. Proper stratification by patients characteristics will allow to understand if LNY and LNR may enter in the future TNM staging system

Conditions

Interventions

DIAGNOSTIC_TEST

Lymph Node Yield (LNY) and Lymph Node Ratio (LNR)

LNY and LNR will be examined after neck dissection

Sponsors & Collaborators

  • University of Roma La Sapienza

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2022-01-01
Completion
2024-01-01

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03534778 on ClinicalTrials.gov